Caroline Gordon1, 2, 3, Maame-Boatemaa Amissah-Arthur1, Mary Gayed1, 3, Sue Brown4,
Ian N. Bruce5, 6, David D'Cruz7, Benjamin Empson8, Bridget Griffiths9, David Jayne10, 11 …

Systemic lupus erythematosus (SLE) is a complex autoimmune disease with multiorgan
manifestations, including pleuropulmonary involvement (20–90%). The precise mechanism …

Objectives To develop recommendations for the management of adult and paediatric lupus
nephritis (LN). Methods The available evidence was systematically reviewed using the …

Objectives Lupus nephritis (LN) is a serious complication of systemic lupus erythematosus
(SLE). All current treatment regimens include oral steroids, which are associated with severe …

Background Since anecdotal series and small, prospective, controlled trials suggest that
mycophenolate mofetil may be effective for treating lupus nephritis, larger trials are …

In the first part of the review, topical agents and first-line systemic treatment options for
cutaneous lupus erythematosus were discussed whereas in the second part, recent …

Immunosuppressive drugs have become the gold standard for the treatment of major organ
involvement in systemic lupus erythematosus. The use of immunosuppressive therapy in …

Class V lupus nephritis (LN) occurs in one-fifth of biopsy-proven cases of systemic lupus
erythematosus. To study the effectiveness of treatments in this group of patients, we pooled …

Arthritis in systemic lupus erythematosus (SLE) is one of the most common disease
manifestations. Nearly all joints can be affected by SLE, but hand and knee involvement are …

Importance Anti–double-stranded DNA (dsDNA) antibody has been reported to have a close
relationship with systemic lupus erythematosus (SLE) flares and participates in the …